Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adiponectin
100%
Adiposity
100%
Anti-inflammatory Properties
10%
Antiatherogenic
10%
Cardiovascular Risk
100%
Glucose Homeostasis
10%
Glucose Tolerance Status
100%
Hemoglobin A1c (HbA1c)
30%
High Cardiovascular Risk
10%
High Risk
10%
High-risk Population
10%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
30%
Impaired Fasting Glucose
10%
Impaired Glucose Regulation
20%
Insulin
20%
Lipids
20%
Low Cardiovascular Risk
10%
Low Risk
10%
Low-risk Group
10%
Normal Glucose Tolerance
20%
Number of Risk Factors
10%
Serum Adiponectin
10%
Type 2 Diabetes Mellitus (T2DM)
10%
Type 2 Diabetic Patients
10%
Medicine and Dentistry
Adiponectin
100%
Anti-Inflammatory Drug
9%
Cardiovascular Risk
100%
Diabetes Mellitus
9%
Glucose Homeostasis
9%
Glucose Tolerance
100%
Hemoglobin A1c
9%
High Risk Population
9%
Homeostatic Model Assessment
27%
Impaired Fasting Glucose
9%
Low Risk Population
9%
Maturity Onset Diabetes of the Young
9%
Patient with Type 2 Diabetes
9%
R Factor
9%
Study Participant
9%
Nursing and Health Professions
Adiponectin
100%
Cardiovascular Risk
100%
Diabetes Mellitus
9%
Glucose Tolerance
100%
Hemoglobin A1c
9%
High Risk Population
9%
Homeostasis Model Assessment
27%
Low Risk Population
9%
Non Insulin Dependent Diabetes Mellitus
9%
Patient with Type 2 Diabetes
9%
R Factor
9%
Study Participant
9%
Pharmacology, Toxicology and Pharmaceutical Science
Adiponectin
100%
Anti-Inflammatory Drug
9%
Cardiovascular Risk
100%
Diabetes Mellitus
9%
Hemoglobin A1c
9%
Non Insulin Dependent Diabetes Mellitus
9%
R-Factor
9%
Immunology and Microbiology
Adiponectin
100%
Glucose Homeostasis
9%
High Risk Population
9%
Insulin
18%
Low Risk Population
9%
R-Factor
9%
Biochemistry, Genetics and Molecular Biology
Adiponectin
100%
Glucose Homeostasis
9%
High Risk Population
9%
Lipid
18%
Low Risk Population
9%
R-Factor
9%